Startup Spotlight: INBRAIN Hopes To Leapfrog Brain Electrode Competition
Executive Summary
By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.
You may also be interested in...
Graphene-Based Devices Face Regulation Questions In Europe
Medtech Insight spoke to two CEOs of start-ups working on graphene-based devices to learn more about how regulation and fears over nanomaterials’ side effects affect device development.
Merck Jumps On Neurostim Technology, Signing Agreements With Start-Ups
The biotech giant signed a commercial agreement with bioelectronics company Innervia, and the two will work collaboratively on vagus nerve stimulating technologies.
UK Regulatory System Progress And New MedTech Directorate Unveiled At Industry Meeting
In the three months since Brexit, UK medtech stakeholders have seen the beginnings of new regulations, foreign trade plans being put in place, and perhaps new perceptions of medtech’s value.